Feng Wen
Direktor/Vorstandsmitglied bei Cyagen Suzhou Biosciences Technology Co., Ltd.
Profil
Feng Wen is currently the Director at Cyagen Suzhou Biosciences Technology Co., Ltd.
He is also a Member-Supervisory Board at Taikang Insurance Group, Inc. and the General Manager at Chizhou Cms Zhong.
An Equity Investment Management Co. Ltd.
In the past, he worked as the Director & Deputy General Manager at Luxin Venture Capital Group Co., Ltd., Principal at China Merchants Securities Co., Ltd., and General Manager at China Merchants Zhiyuan Capital Investment Co., Ltd.
He also served as a Director at Shanghai DOBE Cultural & Creative Ind Dev (Group) Co., Ltd.
from 2018 to 2023.
Mr. Wen holds an MBA from China Europe International Business School and an undergraduate degree from Xiamen University.
Aktive Positionen von Feng Wen
| Unternehmen | Position | Beginn |
|---|---|---|
| Chizhou Cms Zhong An Equity Investment Management Co. Ltd. | Corporate Officer/Principal | 01.11.2015 |
Taikang Insurance Group, Inc.
 Taikang Insurance Group, Inc. Insurance Brokers/ServicesFinance Taikang Insurance Group, Inc. provides insurance and financial setvices. It operates through the following business segments: Insurance, Asset management, and Health and elderly care. The company was founded by Dong Sheng Chen on September 9, 1996 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 01.09.2018 |
Cyagen Suzhou Biosciences Technology Co., Ltd.
 Cyagen Suzhou Biosciences Technology Co., Ltd. BiotechnologyHealth Technology Cyagen Suzhou Biosciences Technology Co., Ltd. specializes in producing custom-engineered mouse and rat models, as well as providing services such as viral packaging, vector cloning, stem cells, and cell culture reagents. The company is based in Taicang, China and was founded in 2011. Cyagen is known for its top-quality services, full guarantee, and competitive prices. The Chinese company also offers mouse embryo and sperm cryopreservation services to protect valuable strains and reduce costs. The protein encoded by the rag2 gene is critical for v(d)j recombination during B and T cell maturation, and Cyagen's services have become well-known for their role in this process. The CEO is Lan Qing Han. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Feng Wen
| Unternehmen | Position | Ende |
|---|---|---|
| SHANGHAI DOBE CULTURAL & CREATIVE INDUSTRY DEVELOPMENT (GROUP)CO. LTD. | Direktor/Vorstandsmitglied | 02.12.2023 |
| China Merchants Zhiyuan Capital Investment Co., Ltd. | Corporate Officer/Principal | 01.05.2013 |
| CHINA MERCHANTS SECURITIES CO., LTD. | Corporate Officer/Principal | 01.07.2009 |
| LUXIN VENTURE CAPITAL GROUP CO., LTD. | Direktor/Vorstandsmitglied | 01.06.2000 |
Ausbildung von Feng Wen
| Xiamen University | Undergraduate Degree |
| China Europe International Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| LUXIN VENTURE CAPITAL GROUP CO., LTD. | Process Industries |
| CHINA MERCHANTS SECURITIES CO., LTD. | Finance |
| SHANGHAI DOBE CULTURAL & CREATIVE INDUSTRY DEVELOPMENT (GROUP)CO. LTD. | Finance |
| Private Unternehmen | 4 |
|---|---|
| China Merchants Zhiyuan Capital Investment Co., Ltd. | Finance |
| Chizhou Cms Zhong An Equity Investment Management Co. Ltd. | |
Taikang Insurance Group, Inc.
Taikang Insurance Group, Inc. Insurance Brokers/ServicesFinance Taikang Insurance Group, Inc. provides insurance and financial setvices. It operates through the following business segments: Insurance, Asset management, and Health and elderly care. The company was founded by Dong Sheng Chen on September 9, 1996 and is headquartered in Beijing, China. | Finance |
Cyagen Suzhou Biosciences Technology Co., Ltd.
Cyagen Suzhou Biosciences Technology Co., Ltd. BiotechnologyHealth Technology Cyagen Suzhou Biosciences Technology Co., Ltd. specializes in producing custom-engineered mouse and rat models, as well as providing services such as viral packaging, vector cloning, stem cells, and cell culture reagents. The company is based in Taicang, China and was founded in 2011. Cyagen is known for its top-quality services, full guarantee, and competitive prices. The Chinese company also offers mouse embryo and sperm cryopreservation services to protect valuable strains and reduce costs. The protein encoded by the rag2 gene is critical for v(d)j recombination during B and T cell maturation, and Cyagen's services have become well-known for their role in this process. The CEO is Lan Qing Han. | Health Technology |
